Kerri Fitzgerald

DocwireNews

Here are the top stories covered by DocWire News&nbsp;this week in the Hematology &amp; Oncology section. This week, various studies from the 2019 ASH Annual Meeting focused on outcomes of chimeric antigen receptor (CAR) T-cell treatments, CVS announced it will provide genetic sequencing for some patients with cancer, and more.CVS Health Corp said it <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/cvs-pharmacy-will-increase-genetic-testing-options-for-cancer/">will provide more patients with advanced cancer</a> who are enrolled in some Aetna insurance plans the opportunity to receive broad&nbsp;genetic sequencing tests&nbsp;to help identify the most optimal treatment plan.Long-term results from the ZUMA-1 trial presented at the 2019 ASH Annual Meeting found that three years after <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/long-term-survival-observed-with-car-t-cell-therapy-for-b-cell-lymphoma/">infusion of the&nbsp;CAR T-cell therapy</a> axicabtagene ciloleucel, nearly half (n=47; 47%) of patients with refractory large B-cell lymphoma were alive.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/bcma-car-t-therapy-for-multiple-myeloma-induces-100-response/">A B-cell maturation antigen</a>&nbsp;CAR T-cell therapy resulted in a 100% response rate among patients with heavily pretreated relapsed/refractory multiple myeloma, according to a study presented at the 2019 ASH Annual Meeting.<a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/common-antibiotic-may-help-fight-cancer-given-before-radiation/">Administering a dose of the common antibiotic</a> vancomycin before radiation therapy may help immune cells kill tumors, according to a new study published in the&nbsp;Journal of Clinical Investigation.A randomized trial found <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/denosumab-flops-in-breast-cancer-study/">no benefit of adjuvant denosumab</a> in&nbsp;early breast cancer.In case you missed it, more hem/onc headlines are featured below:<ul>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/trastuzumab-deruxtecan-is-a-potential-treatment-option-for-her2-breast-cancer/">Trastuzumab Deruxtecan Is a Potential Treatment Option for HER2+ Breast Cancer</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/breast-cancer-incidence-differs-among-black-and-white-males/">Breast Cancer Incidence Differs Among Black and White Males</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/experts-advise-caution-when-interpreting-cancer-study-findings/">Experts Advise Caution when Interpreting Cancer Study Findings</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/lung-cancer-patients-taking-common-medication-often-excluded-from-clinical-trials/">Lung Cancer Patients Taking Common Medication Often Excluded from Clinical Trials</a></li>
<li><a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/two-duvelisib-doses-effective-in-relapsed-refractory-peripheral-t-cell-lymphoma/">Two Duvelisib Doses Effective in Relapsed/Refractory Peripheral T-cell Lymphoma</a></li>
</ul>

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Hem/Onc Roundup: Antibiotic Use Prior to Radiation, Long-Term Survival With CAR-T, and more

Oncology

Here are the top stories covered by DocWire News this week in the Hematology &amp; Oncology section. This week, various studies from the 2019 ASH Annual Meeting focused on ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe